NO843979L - Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater

Info

Publication number
NO843979L
NO843979L NO843979A NO843979A NO843979L NO 843979 L NO843979 L NO 843979L NO 843979 A NO843979 A NO 843979A NO 843979 A NO843979 A NO 843979A NO 843979 L NO843979 L NO 843979L
Authority
NO
Norway
Prior art keywords
aminoalkyl
benzyl
preparation
therapeutic active
analogy procedure
Prior art date
Application number
NO843979A
Other languages
English (en)
Other versions
NO165239B (no
NO165239C (no
Inventor
Karl-Heinz Weber
Gerhard Walther
Claus Schneider
Dieter Hinzen
Franz Josef Kuhn
Erich Lehr
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of NO843979L publication Critical patent/NO843979L/no
Publication of NO165239B publication Critical patent/NO165239B/no
Publication of NO165239C publication Critical patent/NO165239C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
NO843979A 1983-10-04 1984-10-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater. NO165239C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833336024 DE3336024A1 (de) 1983-10-04 1983-10-04 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel

Publications (3)

Publication Number Publication Date
NO843979L true NO843979L (no) 1985-04-09
NO165239B NO165239B (no) 1990-10-08
NO165239C NO165239C (no) 1991-01-16

Family

ID=6210932

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843979A NO165239C (no) 1983-10-04 1984-10-03 Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.

Country Status (27)

Country Link
US (4) US4767759A (no)
EP (1) EP0136658B1 (no)
JP (2) JPS6094959A (no)
KR (1) KR910007882B1 (no)
AR (1) AR243503A1 (no)
AU (1) AU565839B2 (no)
CA (1) CA1242193A (no)
CS (2) CS244148B2 (no)
DD (1) DD227963A5 (no)
DE (2) DE3336024A1 (no)
DK (1) DK164049C (no)
ES (3) ES536469A0 (no)
FI (1) FI78464C (no)
GR (1) GR80546B (no)
HK (1) HK75892A (no)
HU (1) HU193229B (no)
IE (1) IE58155B1 (no)
IL (1) IL73125A (no)
NO (1) NO165239C (no)
NZ (1) NZ209759A (no)
PH (1) PH23764A (no)
PL (2) PL145630B1 (no)
PT (1) PT79306B (no)
SG (1) SG44192G (no)
SU (2) SU1373318A3 (no)
YU (2) YU43858B (no)
ZA (1) ZA847755B (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
DE3634220A1 (de) * 1986-10-08 1988-04-14 Boehringer Ingelheim Kg Verwendung von 1-benzyl-aminoalkyl-pyrrolidinonen als antidepressiva
DE3706399A1 (de) * 1987-02-27 1988-09-08 Boehringer Ingelheim Kg Mittel mit antidepressiver wirkung
WO1988009330A1 (en) * 1987-05-20 1988-12-01 Zambon Group S.P.A. Isoxazoles with nootropic activity
US4772601A (en) * 1988-01-25 1988-09-20 Hoechst-Roussel Pharmaceuticals, Inc. 5-Substituted 1-(4-(1-pyrrolidinyl)-2-butynyl)-2-pyrrolidinones, pharmaceutical compositions and use
EP0342613B1 (en) * 1988-05-20 1992-11-11 ZAMBON GROUP S.p.A. Compounds with central analgesic activity, process for their preparation and pharmaceutical compositions containing them
CA2007732A1 (en) * 1989-01-17 1990-07-17 Gary L. Olson Cyclohexaneacetamide derivatives
IT1231477B (it) * 1989-07-12 1991-12-07 Sigma Tau Ind Farmaceuti (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti
US5066663A (en) * 1990-05-21 1991-11-19 Warner-Lambert Company Substituted-hetero-cyclopentanones and cyclopentenones and derivatives thereof acting at muscarinic receptors
JPH083023Y2 (ja) * 1991-05-21 1996-01-29 株式会社四国総合研究所 太陽電池モジュール用架台
US5538985A (en) * 1994-01-27 1996-07-23 Mitsui Toatsu Chemicals, Inc. Pyrrolidinone derivatives
AU715603B2 (en) * 1996-04-03 2000-02-03 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
US6001835A (en) * 1996-04-03 1999-12-14 Merck & Co., Inc. Inhibitors of farnesyl-protein transferase
AU740616B2 (en) * 1996-06-21 2001-11-08 Syntroleum Corporation Synthesis gas production system and method
PE17599A1 (es) 1996-07-09 1999-02-22 Syntroleum Corp Procedimiento para convertir gases a liquidos
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5950732A (en) * 1997-04-02 1999-09-14 Syntroleum Corporation System and method for hydrate recovery
AU9690298A (en) * 1997-10-10 1999-05-03 Syntroleum Corporation System and method for converting light hydrocarbons to heavier hydrocarbons withseparation of water into oxygen and hydrogen
US6362201B1 (en) 1999-03-02 2002-03-26 Merck & Co., Inc. 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity
US6489354B1 (en) 1999-03-02 2002-12-03 Merck & Co., Inc. 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity
US6372764B1 (en) 1999-03-02 2002-04-16 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6794417B2 (en) 2002-06-19 2004-09-21 Syntroleum Corporation System and method for treatment of water and disposal of contaminants produced by converting lighter hydrocarbons into heavier hydrocarbon
ES2377484T3 (es) * 2003-09-03 2012-03-28 Pfizer, Inc. Compuestos de bencimidazolona que tiene actividad agonista del receptor 5-HT
AU2005254800B2 (en) 2004-06-15 2010-12-09 Pfizer Inc. Benzimidazolone carboxylic acid derivatives
GR1004905B (el) * 2004-07-14 2005-05-27 Ε.Ι.Ε. (Εθνικο Ιδρυμα Ερευνων) Καινοτομα αντιυπερτασικα προιοντα
FR2940609B1 (fr) * 2008-12-30 2011-05-06 Oreal Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3133082A (en) * 1960-06-09 1964-05-12 Mead Johnson & Co 1-substituted-3-pyrrolidylmethylamines
NL136272C (no) * 1962-07-13
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
BE791606A (fr) * 1972-07-10 1973-03-16 Pilot Pen Co Ltd Procede et appareil pour aspirer et soulever la feuille la plussuperieure d'une pile de feuilles de ce type
JPS5244559A (en) * 1975-10-06 1977-04-07 Ise Electronics Corp Fluorescent display tube with luminescent diode
JPS5346966A (en) * 1976-10-06 1978-04-27 Teijin Ltd Lactamamines and their preparation
JPS5344559A (en) * 1976-10-06 1978-04-21 Teijin Ltd New urethanes and their preparation
FR2387218A1 (fr) * 1977-04-15 1978-11-10 Ile De France Nouveaux n-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides, leurs procedes de preparation et leur application comme modificateurs du comportement
AU518986B2 (en) * 1977-10-11 1981-10-29 Takeda Chemical Industries Ltd. Lactams
CU21107A3 (es) * 1978-02-10 1988-02-01 Hoffmann La Roche Pyrrolidines derivatives
CA1115212A (en) * 1978-02-10 1981-12-29 Emilio Kyburz Pyrrolidine derivatives
DE2923975A1 (de) * 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2924011C2 (de) * 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
CH657527A5 (de) * 1980-02-13 1986-09-15 Ciba Geigy Ag Verwendung von zentralnervoes-wirksamen verbindungen in einem mittel, welches zur verhinderung oder linderung von nebenwirkungen bestimmt ist.
CH646149A5 (de) * 1981-02-05 1984-11-15 Hoffmann La Roche Pyrrolidin-derivat.
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
FR2549053B1 (fr) * 1983-07-12 1985-12-27 Sanofi Sa Nouveaux derives de la pyrrolidine actifs sur le systeme nerveux central, leur procede de preparation, les medicaments en contenant
DE3326724A1 (de) * 1983-07-25 1985-02-07 Boehringer Ingelheim KG, 6507 Ingelheim In 1-stellung substituierte 4-hydroxymethyl-pyrrolidinone, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen und zwischenprodukte
DE3336024A1 (de) * 1983-10-04 1985-04-18 Boehringer Ingelheim KG, 6507 Ingelheim 4-amino-l-benzyl-pyrrolidinone und ihre saeureadditionssalze, verfahren zu ihrer herstellung und arzneimittel
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel

Also Published As

Publication number Publication date
AU565839B2 (en) 1987-10-01
DD227963A5 (de) 1985-10-02
CS153784A2 (en) 1985-08-15
IE842519L (en) 1985-04-04
ES8505652A1 (es) 1985-06-01
JPS6094959A (ja) 1985-05-28
FI843856L (fi) 1985-04-05
FI78464C (fi) 1989-08-10
FI78464B (fi) 1989-04-28
JPH0739387B2 (ja) 1995-05-01
JPH046684B2 (no) 1992-02-06
ES539884A0 (es) 1985-11-16
CS244148B2 (en) 1986-07-17
ES8601877A1 (es) 1985-11-16
NO165239B (no) 1990-10-08
SU1373318A3 (ru) 1988-02-07
CS410891A3 (en) 1992-08-12
ES539883A0 (es) 1985-11-16
PT79306B (de) 1986-11-13
PL145630B1 (en) 1988-10-31
DK474684D0 (da) 1984-10-03
YU43858B (en) 1989-12-31
US4833140A (en) 1989-05-23
HK75892A (en) 1992-10-09
DE3336024A1 (de) 1985-04-18
PL253280A1 (en) 1986-02-11
JPH04261152A (ja) 1992-09-17
IE58155B1 (en) 1993-07-14
US5073671A (en) 1991-12-17
CA1242193A (en) 1988-09-20
KR850003393A (ko) 1985-06-17
YU199086A (en) 1987-10-31
GR80546B (en) 1985-02-05
NZ209759A (en) 1989-04-26
KR910007882B1 (ko) 1991-10-04
AU3383484A (en) 1985-04-18
YU169684A (en) 1987-10-31
EP0136658A2 (de) 1985-04-10
PL145637B1 (en) 1988-10-31
PL249852A1 (en) 1985-09-10
SU1306472A3 (ru) 1987-04-23
IL73125A0 (en) 1984-12-31
US4996224A (en) 1991-02-26
HUT35641A (en) 1985-07-29
DK164049C (da) 1992-09-28
DK164049B (da) 1992-05-04
NO165239C (no) 1991-01-16
YU43901B (en) 1989-12-31
DK474684A (da) 1985-04-05
FI843856A0 (fi) 1984-10-02
DE3477922D1 (en) 1989-06-01
EP0136658A3 (no) 1985-06-05
US4767759A (en) 1988-08-30
SG44192G (en) 1992-09-04
PT79306A (de) 1984-11-01
ZA847755B (en) 1986-06-25
EP0136658B1 (de) 1989-04-26
PH23764A (en) 1989-11-03
IL73125A (en) 1988-10-31
AR243503A1 (es) 1993-08-31
ES536469A0 (es) 1985-06-01
HU193229B (en) 1987-08-28
ES8601878A1 (es) 1985-11-16

Similar Documents

Publication Publication Date Title
NO841568L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenetanolamin-derivater
NO843979L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater
NO168770C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO170629C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO171638C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin-derivater
NO164301C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefalosporinderivater.
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO168355C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO167026C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater
NO843084L (no) Fremgangsmaate for fremstilling av terapeutisk aktive adenosin-derivater
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO164169C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzothiazinderivater.
NO168299C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater
NO840212L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive aminosyre-derivater
NO843042L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kumarin-derivater
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO169069C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater
NO833527L (no) Fremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklobutylderivater
NO820112L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridoindol-derivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN APRIL 2003